Alison Cecily Finger is CCO at bluebird bio, Inc. (BLUE). They have made 14 open-market trades across 1 company since 2018, most recently 2026-02-09.
CIK 0001731164
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 14 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BLUE | SELL | 2021-01-05 | 2021-01-08 | $45.05 | $84K | -5.6% | -3.5% | -41.8% |
| BLUE | SELL | 2020-12-02 | 2020-12-04 | $46.20 | $2K | -5.4% | -5.0% | -40.6% |
| BLUE | SELL | 2020-11-02 | 2020-11-04 | $52.99 | $2K | -4.0% | -3.0% | -4.0% |
| BLUE | SELL | 2020-10-02 | 2020-10-06 | $52.77 | $2K | -0.4% | -13.3% | -20.7% |
| BLUE | SELL | 2020-09-03 | 2020-09-08 | $58.60 | $2K | -0.1% | +1.8% | -20.0% |
| BLUE | SELL | 2020-08-03 | 2020-08-05 | $60.49 | $2K | -1.5% | -10.9% | -13.7% |
| BLUE | SELL | 2020-07-02 | 2020-07-07 | $61.57 | $2K | +2.8% | -0.9% | -12.9% |
| BLUE | SELL | 2020-06-02 | 2020-06-04 | $64.04 | $2K | -7.0% | -14.4% | -12.5% |
| BLUE | SELL | 2020-01-07 | 2020-01-09 | $89.97 | $189K | +2.9% | -0.6% | -52.8% |
| BLUE | SELL | 2020-01-03 | 2020-01-07 | $84.96 | $44K | +9.4% | +0.4% | -51.6% |
| BLUE | SELL | 2019-01-07 | 2019-01-09 | $113.63 | $73K | +14.1% | +19.3% | +42.2% |
| BLUE | SELL | 2019-01-03 | 2019-01-09 | $99.31 | $47K | +14.1% | +19.3% | +42.2% |
| BLUE | SELL | 2019-01-03 | 2019-01-07 | $99.31 | $43K | +10.4% | +18.7% | +39.8% |
| BLUE | SELL | 2018-08-20 | 2018-08-22 | $158.07 | $41K | +2.1% | -13.1% | -28.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.